European startups secured approximately $42 million in funding across three notable deals on September 24, 2026. The capital was concentrated in AI infrastructure, precision oncology, and biotechnology, with investors focusing on projects that support the foundation of the digital and health economy.
Kasvu Therapeutics, based in Helsinki, raised €30 million in a Series A round led by Hadean Ventures. The company develops neuroplasticity drugs for treatment-resistant depression. The funds will support clinical development and team expansion in Finland.
Naples-based Clastix secured €2.9 million in a seed round led by CDP Venture Capital Sgr, with participation from Mistral AI and Vertis SGR. The startup provides Kubernetes management software, kMetal, designed to improve efficiency for AI-scale workloads on bare-metal servers.
Prevision Medicine, headquartered in Switzerland, raised $5.4 million in seed funding led by ACE Ventures. The company’s platform, PrevisionOne, uses single-cell assays to determine tumor cell responses to drug combinations. The capital will be used for regulatory approvals and scaling operations.
